Top Markets
#1 Islamic Coin Islamic Coin +151.22%
#2 Akedo Akedo +76.34%
#3 Velvet Velvet +52.62%
#4 Glidr Glidr +51.75%
#5 DOVU DOVU +47.94%
#6 Black Phoenix Black Phoenix +33.93%
#7 Cross Cross +31.13%
#8 Cap Cap +21.55%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.55%
#10 DoubleZero DoubleZero +14.82%
Coin of the day
Islamic Coin Islamic Coin
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
HVIVO plc HVIVO plc

HVIVO plc

HVO
Classificação em ações #39190
hVIVO plc (HVO) operates as a premier full-service Contract Research... hVIVO plc (HVO) operates as a premier full-service Contract Research Organisation (CRO) focused on early-phase clinical development, globally recognized as the leader in human challenge trials. The company provides a complete spectrum of clinical development services to a wide-ranging and growing client base, which includes seven of the world's ten largest biopharmaceutical companies. A key specialisation for hVIVO is orchestrating human challenge trials across numerous infectious and respiratory diseases, utilising its advanced, London-based quarantine facility, the largest of its kind globally. Additionally, the company offers extensive virology and immunology laboratory services through its hLAB division. Through its German subsidiary, CRS, hVIVO manages a 120-bed capacity across sites in Mannheim and Kiel, delivering early-phase clinical trial expertise, including first-in-human and proof-of-concept studies. Its other subsidiary, Venn Life Sciences, contributes to the biopharma sector by providing specialist early drug development consulting and biometry services. The Group collectively offers integrated drug development solutions, covering stages from preclinical research up to Phase II trials, supported by patient recruitment via FluCamp. Moreover, its five clinical sites facilitate outpatient Phase II and III trials, ensuring a streamlined and effective transition from drug discovery to late-stage development.
Preço da ação
$0.0884456
Valor de mercado
$608.86K
Variação (1 dia)
-2.99%
Variação (1 ano)
-36.22%
País
GB
Negociar HVIVO plc (HVO)

Categoria

Healthcare
Histórico de preços das ações de HVIVO plc (HVO)
Preço de fecho mais alto: $0.09 em 2026-08-01

Preço de fecho mais baixo: $0.55 em 2012-12-01
Histórico de preços das ações da HVIVO plc de 2012 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 25.51%
2025 -69.91%
2024 -3.74%
2023 98.73%
2022 -51.22%
2021 -10.78%
2020 335.59%
2019 194.91%
2018 -84.83%
2017 -45.35%
2016 -9.46%
2015 14.83%
2014 -31.84%
2013 -23.92%
2012 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 32.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 31.47%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $728.05 6.60%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $254.79 12.56%
BE